摘要
目的观察国产肺泡表面活性物质(珂立苏)联合鼻塞式持续气道正压通气(N-CPAP)预防早产儿呼吸窘迫综合征(RDS)的效果。方法将18例孕32周前出生且在出生后6 h内入NICU的早产儿,在常规治疗的基础上,经气管插管滴入珂立苏后拔管,联合N-CPAP辅助呼吸,观察应用珂立苏前、后血气分析指标(动脉氧分压及二氧化碳分压)的变化、X线胸片的变化以及N-CPAP参数的变化(氧浓度、呼气末正压)。结果应用珂立苏联合N-CPAP预防RDS,可明显改善血气指标及氧合情况;N-CPAP参数(FiO2、PEEP)明显下调。结论珂立苏联合N-CPAP预防RDS疗效确切,可明显改善血气指标及氧合状况、下调N-CPAP所需的参数、缩短N-CPAP使用的总时间。
Objective To observe the effect of domestic(China) pulmonary surfactant-Calsurf,joint with n-CPAP in preventing premature infants from Respiratory Distress Syndrome(RDS).Methods Select 18 cases of premature infants before 32 weeks gestational age who were admitted to NICU within 6 hours after birth.Based on conventional treatment,we remove the tube after Calsurf being instilled into the trachea and the n-CPAP ventilation was set.Then we observe the changes of the blood gas analysis elements-PO2 PCO2,X-ray of chest and the parameter of n-CPAP(FiO2 PEEP).Results Calsurf joint with n-CPAP can significantly improve blood gas analysis indications of blood gas analysis and PO2.It can also improve the x-ray of chest and meanwhile reduce the parameter of n-CPAP(FiO2 PEEP).Conclusion It is effective to use Calsurf joint with n-CPAP to prevent premature infants from respiratory distress syndrome(RDS).It can significantly improve blood gas analysis PO2 and meanwhile reduce the parameter of n-CPAP.As a result,total time of n-CPAP can be shortened.
出处
《安徽医学》
2010年第6期652-654,共3页
Anhui Medical Journal
关键词
肺泡表面活性物质
早产儿
呼吸窘迫综合征
The alveolar surface active substances
Premature
Respiratory distress syndrome